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ABSTRACT
Background. Muscle depletion is a poor prognostic indi-
cator in colorectal cancer (CRC) patients, but there were no
data assessing comparative temporal body composition
changes following elective CRC surgery. We examined
patient skeletal muscle index trajectories over time after
surgery and determined factors that may contribute to those
alterations.
Methods. Patients diagnosed with CRC undergoing elec-
tive surgical resection between 2006 and 2013 were
included in this study. Image analysis of serial computed
tomography (CT) scans was used to calculate lumbar
skeletal muscle index (LSMI). A multilevel mixed-effect
linear regression model was applied using STATA (version
12.0) using the xtmixed command to fit growth curve
models (GCM) for LSMI and time.
Results. In 856 patients, a total of 2136 CT images were
analyzed; 856 (38.2 %) were preoperative. A quadratic
GCM with random intercept and random slope for patients’
LSMI was identified that demonstrated laparoscopy pro-
duces a positive change on the LSMI curve
[estimate = 0.17 cm2/m2, standard error (SE) 0.06 cm2/
m2; p = 0.03], whereas Union for International Cancer
Control (UICC) stage III ? IV disease contributed to a
negative curve change (estimate = -0.19 cm2/m2,
SE 0.09 cm2/m2; p = 0.03). Older age (p\ 0.01), female
gender (p\ 0.01), higher American Society of Anesthe-
siologists (ASA) score (p\ 0.01), and altered systemic
inflammatory response [SIR] (p = 0.03) were factors sig-
nificantly associated with lower values of LSMI over time.
Conclusion. In patients undergoing CRC surgery, laparo-
scopy and the absence of a significantly elevated SIR
favored preservation and restoration of skeletal muscle,
postoperatively. These emerging data may permit the
development of new treatment protocols whereby moni-
toring and modification of body composition has
therapeutic potential.
It is becoming increasingly clear that a variety of body
composition changes occur in cancer patients, and that
muscle depletion is a common, albeit in most, occult fea-
ture. Muscle depletion is characterized by reduction in
muscle size (myopenia) and an increased infiltration by
inter- and intramuscular fat, described as myosteatosis.1,2
The incidence of muscle depletion varies from 15 to 70 %
for patients treated for CRC,3 and evidence also demon-
strates that muscle depletion is associated with poorer
outcomes in patients treated for cancer.4,5 For CRC patients
treated surgically, myopenia negatively impacts short-term
outcomes, including mortality, morbidity, and functional
recovery.3 Muscle depletion, estimated from CTBC anal-
ysis, has also been found to be a prognostic factor for
developing severe toxicity in CRC patients receiving
chemotherapy.6 Finally, emerging data suggest that
myopenia can be an independent predictor of poorer sur-
vival after CRC treatment; however, neither the point of
onset of muscle depletion nor the patterns of muscle
alterations over time and their precipitants are known.
Therefore, there is a need to identify whether body com-
position changes assessable by surveillance imaging after
CRC can be related to specific clinicopathological or
treatment factors that, once identified, might allow muscle
depletion to be contained or modified.
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Growth curve modeling (GCM) is an advanced method
for demonstrating within-patient and between-patient
variation in outcomes measured across different time
points over a follow-up period.7 The GCM approach has
allowed researchers to overcome problems in studies that
assess comparisons of the intraindividual changes over
time. More traditional methods examining changes of time,
such as analysis of variance and analysis of covariance, are
problematic and are limited, mandating accuracy in equal
group sizes, a condition that is very difficult to meet.8,9
Using the GCM approach, we aimed to not only
examine how patient body composition, as determined by
skeletal muscle index trajectories, varied over time after
elective surgery for CRC but also to determine specific
factors that may contribute to alterations over time.
METHODS
Patient Population
Overall, 1477 consecutive patients undergoing CRC
surgery at St Mark’s Hospital, London, between January
2006 and December 2013, were identified from a
prospective database. Patients with recorded height data,
laboratory blood test data within 4 weeks of staging com-
puted tomography (CT) scan and preoperative staging, and
surveillance CT images stored and retrievable in an elec-
tronic format suitable for image analysis were included in
the study. Exclusions were patients with disease recurrence
confirmed preoperatively or at surgery, and emergency
operations. All prospectively recorded clinical and patho-
logical data were revalidated from medical and
histopathology records. Data collected prospectively dur-
ing the perioperative period (within 30 days of surgery)
included age, sex, body mass index (BMI), American
Society of Anesthesiologists (ASA) physical status classi-
fication system, tumor site, TNM stage [Union for
International Cancer Control (UICC) 5 version] and sur-
gical approach. Laboratory blood test data collected
included preoperative neutrophil and lymphocyte counts.
The neutrophil to lymphocyte ratio (NLR) was derived as a
valid reflection of the host systemic inflammatory response
(SIR);10 a high NLR [HNLR] was defined as[3.0.
Body Composition Analysis
Serial CT scan images performed as part of the CRC
follow-up protocol were retrieved from digital storage in
the picture archiving and communication system (PACS).
CT image analysis Slice-O-Matic V4.3 software (Tomo-
vision, Montreal, QC, Canada) was performed as described
previously.11 Briefly, total skeletal muscle surface areas
(cm2) were evaluated on a single image at the third lumbar
vertebrae (L3) using Hounsfield unit (HU) thresholds of
-29 to 150 for skeletal muscle, -50 to 150 for visceral
adipose tissue, and -190 to -30 for subcutaneous adipose
tissues. The sum of skeletal cross-sectional muscle areas
was normalized for stature (m2) and reported as lumbar
skeletal muscle index (LSMI) [cm2m-2].
Data Analysis
A non-parametric Mann–Whitney U test was used to
determine significant differences between the LSMI from
baseline demographic and clinicopathological characteris-
tics (a p value\ 0.05 was regarded as significant), and a
multi-level, mixed-effect GCM was applied using STATA
version 12.0 (StataCorp LP, College Station, TX, USA).12
GCM is a special case of random–coefficient models where
the coefficient of time varies randomly between subjects.
Growth trajectories can take a variety of shapes. A flexible
approach to model possible non-linear growth in Yij is to
use a pth degree polynomial function of time tij; Y ij ¼
b1 constantð Þ þ b2:tij linearð Þþ b3:t2ij quadraticð Þ þ . . .þ
b:p þ 1tpij þ nij.
Using the xtmixed command, we modeled the shape of
trajectories of the dependent variable (LSMI) over time and
how these trajectories varied due to time- and patient-level
covariates. A number of steps were considered in speci-
fying a repeated measures analysis using a GCM approach,
as described by Rabe-Hesketh and Skrondal.12 Penalized-
likelihood information criteria, such as Akaike’s informa-
tion criterion (AIC) and the Bayesian information criterion
(BIC) were used for model selection. Heteroscedasticity
checks were also performed. Heteroscedasticity refers to
the circumstance in which the observed variance is inde-
pendent of the variable mean.13
RESULTS
Study Population
The clinicopathological characteristics of the 856 elec-
tive colorectal cancer (CRC) resection cases that fulfilled
the selection criteria are provided in Table 1. The median
age at operation was 67 years [interquartile range (IQR)
58–76]. Overall, 63.1 % of patients were treated laparo-
scopically [intention-to-treat] (63.1 % laparoscopic vs.
36.9 % open); 238 (27.8 %) were rectal cancers. The
majority of the operations were performed or supervised by
one of two consultant colorectal surgeons (RHK and JTJ)
who were designated CRC surgeons and were both trained
in laparoscopic colorectal surgery, with the laparoscopic
technique being standardized between surgeons. These two
G. Malietzis et al.
surgeons performed both open and laparoscopic colorectal
resections. Additional cases were performed by three other
surgeons using mainly open techniques or by laparoscopy,
with mentoring by the two laparoscopic colorectal sur-
geons. The selection for open or laparoscopic surgery
reflected each individual surgeon’s expertise during the
study period, and all patients were part of an enhanced
recovery after surgery (ERAS) protocol for recovery. A
total of 2136 CT images were analyzed, of which 856
(38.2 %) were pretreatment scans.
Body Composition Analysis
The median LSMI was 42.9 (IQR 37.4–49.5) cm2m2,
and men had a higher LSMI compared with women
(p\ 0.001). Elderly patients, patients with a high ASA or
high NLR preoperatively, or patients with a colon cancer
had significantly lower LSMI median values compared
with patients aged \65 years (p\ 0.001), ASA I ? II
(p\ 0.001), NLR\ 3.0 (p\ 0.001), and patients with
rectal cancers (p = 0.016), respectively. No differences
were noted between the preoperative LSMI and the type of
surgical approach (laparoscopic vs. open; p = 0.710) or the
UICC stage (p = 0.056). The CT-derived LSMI values and
their associations with different clinicopathological vari-
ables are summarized in Table 2.
Model Fit Non-linear Growth
Patient LSMI change was non-linear over time when the
observed growth trajectories were plotted. As the rela-
tionship between LSMI over time was non-linear, we
included a quadratic term for time in our model; both time
terms in this model were statistically significant (if the
time2 term had not been statistically significant, we could
have only included a linear term for time in our model).
The estimated standard deviation (SD) of the random
intercept was 8.53 (95 % confidence interval [CI] 8.09–
9.00) and the estimated SD of the error was 3.22 (95 % CI
3.09–3.36). We then included a random slope on time, to
permit variability between patients in relation to overall
rates of LSMI change. The SD of the random coefficient on
time was 0.27 (95 % CI 0.14–0.53), indicating hetero-
geneity between the rates of change in LSMI. In addition,
the estimated SD of the error term decreased from 3.22 to
3.17, indicating a better fit of the model.
Quadratic Growth for Patients’ LSMI that Includes
Patient-Level Covariates
Gender At any given time, we estimated that a female
patient’s LSMI was 7.95 cm2/m2 [standard error (SE)
0.58 cm2/m2] less than a male patient’s LSMI. The
coefficients of both time and time2 were significant at the
5 % level. Gender did not exert any effect on the slope of
the curve trajectory as the estimate for gender*time
variable was not significant from the two-stage model
formation.
Age Elderly patients ([65 years of age) had an LSMI, on
average, of 3.79 cm2/m2 (SE 0.11 cm2/m2) less than
younger patients (\ 65years of age). Inclusion of the
age*time variable in a two-stage formation model was not
significant and the fact that the AIC and BIC values were in
favor of the polynomial model; the two-stage formation
model was omitted.
TABLE 1 Clinicopathological characteristics of the 856 elective
colorectal cancer resection cases that fulfilled the selection criteria
Baseline demographics (N = 856) Count %
Gender
Male 482 56.3
Female 374 43.7
Age category (years)
\65 389 45.4
C65 467 54.6
NLR category
Low 318 37.1
High 268 62.9
ASA status
1 ? 2 711 83.1
3 ? 4 145 16.9
Surgical approach
Open 316 36.9
Laparoscopic 540 63.1
Tumor site
Colon 618 72.2
Rectum 238 27.8
UICC stage
I 197 23.0
II 302 35.3
III 283 33.1
IV 74 8.6
BMI categories
Underweight BMI\ 18.5 18 2.2
Normal BMI (18.5–25) 276 32.1
Overweight BMI (25–30) 349 40.8
Obese BMI ([30) 213 24.9
NLR neutrophil to lymphocyte ratio, ASA American Society of
Anesthesiologists physical status, UICC Union for International
Cancer Control, BMI body mass index
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Preoperative Systemic Inflammatory Response Elevated
preoperative SIR, expressed as NLR[ 3.0 (HNLR), had a
significant effect on the LSMI trajectory over time. Patients
with HNLR at any given time point had a lower LSMI at an
average of -2.28 cm2/m2 (SE 0.79 cm2/m2) compared
with the patients with an NLR\ 3.0 (low NLR). The
two-stage formation model had the best-fit values, but NLR
did not have an impact on the slope of the trajectory.
American Society of Anesthesiologists The two-stage
formation model was also the best-fit model when ASA
was considered as a patient-level covariate. Patients with a
higher ASA score (III ? IV) had a significantly lower
LSMI (estimate = -2.68 cm2/m2; SE 0.62 cm2/m2) than
patients with an ASA score of I or II.
Surgical Approach At any given time, for patients who
underwent laparoscopic resection we estimated that their
LSMI was not statistically different than the LSMI of
patients who had an open procedure. The coefficients of
time2 were significant at the 5 % level. The surgical
approach had an impact on the slope of LSMI trajectory as
the estimate for surgical approach*time variable was
significant from the two-stage model formation. Of
interest, patients who underwent a laparoscopic resection
had a positive change to the slope of their LSMI trajectory
compared with the open approach group (estimate =
?0.15 cm2/m2; SE 0.06 cm2/m2). No significant
differences were observed between the preoperative BMI
(p = 0.61), ASA (p = 0.09), age (p = 0.21), NLR
(p = 0.91), and the type of surgical approach.
Tumor Site The two-stage formation model was the best-
fit model when tumor location was considered as the
patient-level covariate. Patients who underwent surgery for
a rectal tumor had a negative change to the slope of their
LSMI trajectory compared with the colon group
(estimate = -0.13 cm2/m2; SE 0.05 cm2/m2).
TABLE 2 LSMI values calculated from the CT analysis and their relationships with the clinicopathological variables
L3 muscle index (LSMI)
Median 25th percentile 75th percentile p value
Gender
Male 47.16 41.20 54.09 \0.001
Female 39.20 34.80 43.56
Age category (years)
\65 45.42 39.58 51.80 \0.001
C65 41.55 35.91 47.66
NLR category
Low 44.25 37.57 52.62 \0.001
High 41.56 36.36 47.47
ASA status
I ? II 44.64 38.90 51.13 \0.001
III ? IV 40.52 35.72 45.56
Surgical approach
Open 43.12 36.31 51.18 0.710
Laparoscopic 43.79 37.90 49.68
Tumor site
Colon 42.81 37.46 49.38 0.016
Rectum 44.73 38.20 51.76
UICC stage
I 45.26 37.69 52.53 0.056
II 41.90 36.86 49.38
III 44.36 38.52 50.35
IV 42.66 37.91 46.88
NLR neutrophil to lymphocyte ratio, ASA American Society of Anesthesiologists, UICC Union for International Cancer Control, L3 third lumbar
vertebrae, LSMI lumbar skeletal muscle index, CT computed tomography
Bold p values indicate statistical significance at p\ 0.05
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Union for International Cancer Control (UICC)
Stage Patients with a higher stage of disease (UICC
stage III ? IV) had a negative change to the slope of their
LSMI trajectory compared with patients with UICC stage
I ? II (estimate = -0.20 cm2/m2; SE 0.09 cm2/m2).
Heteroscedasticity Heteroscedasticity checks were
performed for each of the patient-level covariates under
investigation, and no evidence of heteroscedasticity was
identified.
Figure 1 shows the mean trajectory and 95 % range of
patient-specific trajectories for the different patient-level
covariates. Table 3 summarizes the maximum likelihood
estimates for quadratic models for the patients’ LSMI.
Multivariate Quadratic Growth with Random Intercept
and Random Slope for Patients’ LSMI
To adjust for all patient-level covariates and all statis-
tically significant time covariates, interactions were
considered for the formulation of the final model. Older
age, female gender, high preoperative SIR (HNLR) and
higher ASA were significantly associated with lower LSMI
values over time. Laparoscopy and a more advanced UICC
stage had a significant effect on the slope of the LSMI
trajectory. Laparoscopy offered a positive change on the
LSMI slope (estimate = 0.17 cm2/m2; SE 0.06 cm2/m2),
whereas UICC stage III ? IV contributed to a negative
slope change (estimate = -0.19 cm2/m2; SE 0.09 cm2/
m2). The coefficients of time and time2 were significant at
the 5 % level. The log-likelihood and values for AIC and
BIC were also improved, suggestive of a model of better
fit. Table 4 shows the estimates of the multivariate quad-
ratic growth with random intercept and random slope for
patients’ LSMI.
DISCUSSION
This study applied a flexible method for modeling the
non-linear and asymmetric relationships between body
composition and time for patients treated surgically for
CRC, specifically addressing muscle mass as represented
by LSMI. Using the multilevel GCM approach, we found
that the LSMI–time relation followed a quadratic trajectory
over the postoperative follow-up period of up to
60 months. We identified that patients with older age,
female gender, high preoperative SIR (reported as HNLR
and high ASA) have, on average, a low LSMI over time
compared with their opposite groups. We also demon-
strated that laparoscopy offered a positive change to the
LSMI over time, whereas UICC stage III ? IV was asso-
ciated with a negative change, inferring that muscle mass is
augmented after laparoscopy and depleted with higher
cancer stages. Loss of skeletal mass due to aging is a well-
TABLE 3 Maximum likelihood estimates for quadratic models when the different patient-level factors were investigated
Skeletal muscle index Gender (female
vs. male)
Age, years ([65
vs.\65)
NLR (HNLR vs.
LNLR)
ASA (III ? IV
vs. I ? II)
Surgical approach
(laparoscopic
vs. open)
Tumor site
(rectum vs.
colon)
UICC stage
(III ? IV vs.
I ? II)
Best-fit model Two-stage
formation
Polynomial Two-stage
formation
Two-stage
formation
Two-stage
formation
Two-stage
formation
Two-stage
formation
Fixed part Estimate SE Estimate SE Estimate SE Estimate SE Estimate SE Estimate SE Estimate SE
b 1 (constant) 47.69 (0.38)* 50.15 (0.99)* 45.68 (0.58)* 49.48 (1.65)* 44.54 (0.62)* 42.17 (0.95)* 44.21 (1.10)*
b (variable of interest) -7.95 (0.58)* -3.79 (0.11)* -2.28 (0.79)* -2.68 (0.62)* -0.32 (0.77) 1.67 (0.09) 0.09 (0.73)
b 2 (time linear) 0.30 (0.11)* 0.33 (0.11)* 0.30 (0.13)* 0.05 (0.19) 0.21 (0.15) 0.52 (0.16)* 0.64 (0.17)*
b 3 (time quadratic) -0.03 (0.01)* -0.03 (0.01)* -0.03 (0.01)* -0.01 (0.02) -0.02 (0.01)* -0.03 (0.01)* -0.03 (0.15)*
c (variable*time) 0.13 (0.09) 0.15 (0.10) 0.08 (0.08) 0.15 (0.06)a -0.13 (0.05)* -0.20 (0.09)*
Random part
Bp 7.51 (0.22) 8.27 (0.09) 8.82 (0.29) 8.17 (0.29) 8.79 (0.27) 8.44 (0.24) 8.77 (0.27)
t
p
ij 0.26 (0.10) 0.27 (0.10) 0.31 (0.09) 0.19 (0.16) 0.29 (0.09) 0.26 (0.09) 0.29 (0.09)
nij constantð Þ 0.24 (0.23) 0.01 (0.18) 0.05 (0.17) 0.07 (0.29) 0.09 (0.18) 0.11 (0.19) 0.05 (0.16)
Residual 3.17 (0.08) 3.17 (0.07) 2.93 (0.08) 3.14 (0.09) 3.07 (0.08) 8.44 (0.24) 3.08 (0.08)
Log likelihood -5983.02 -6045.44 -4123.82 -4332.86 -5055.37 -6064.41 -5148.82
AIC 11,984.02 12,106.88 8265.64 8683.71 10,118.38 12,146.82 10,315.64
BIC 12,034.09 12,151.38 8312.36 8730.95 10,166.87 12,196.89 10,364.31
Heteroscedasticity Absent Absent Absent Absent Absent Absent Absent
NLR neutrophil to lymphocyte ratio, ASA American Society of Anesthesiologists, UICC Union for International Cancer Control, HNLR high NLR, LNLR low NLR,
SE standard error, AIC Akaike Information Criterion, BIC Bayesian Information Criterion
* p\ 0.05
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recognized process, but muscle depletion can also be a
consequence of chronic diseases such as cancer.14 The
presence of comorbidities and the effect of the sex hor-
mones are recognized factors that contribute to muscle
metabolism.15,16 Richards et al. previously demonstrated
that CT-derived body composition parameters vary
between the two genders, but subgroup analysis of this
cohort of patients did not reveal any different LSMI tra-
jectories compared with the whole of the cohort;17
however, the pattern of muscle changes after treatment for
cancer has not, to our knowledge, been examined in this
way before.
We have previously demonstrated that, in patients
undergoing CRC surgery, a low NLR favors maintenance
of muscle mass postoperatively. Recent advancements in
the investigation of the pathophysiology of skeletal muscle
depletion and cachexia in cancer patients have suggested
that inflammation could be considered the common link.18
Inflammation plays a vital role in the metabolic and body
composition changes in cancer though five key domains:
systemic inflammation, central energy balance, control of
muscle metabolism/function, control of adipose tissue
metabolism/function, and regulation of appetite.19 An
ongoing state of low-grade inflammation that involves
stimulation of various acute-phase proteins such as C-re-
active protein and proinflammatory cytokines that enhance
autophagy in skeletal muscle and inhibit the synthesis of
myofibrillar proteins, may be the background mechanism
of the effect of systemic inflammation on the muscle tra-
jectory postoperatively.19 Our findings further support the
assertion that resolution of the SIR is a potential approach
to develop more effective therapies against muscle deple-
tion and cancer cachexia.
We identified that laparoscopic resection has a positive
impact on restoration of patient muscle mass postopera-
tively. Multiple randomized trials have confirmed that
laparoscopy for CRC produces equivalent oncological
outcomes as open surgery, and also produces benefits from
decreased complications and hospital stay, decreased
postoperative narcotic analgesia use, a faster return of
bowel function, and improved cosmesis.20,21 We have now
identified that additional benefits include maintenance and
restoration of muscle mass. The associated tissue injuries
from surgical trauma induce immunologic alterations in the
patient that depend on the extent of the injury. Laparo-
scopy, as opposed to open surgery, reduces the systemic
inflammatory changes of surgery and this, along with
reduced complications, may be the mechanism for preser-
vation of muscle.22 The relative preservation of health
during the first year after laparoscopic surgery may be the
mechanism underlying reports of improved cancer out-
comes compared with conventional open colorectal
resection. Recent work from our group (Malietzis et al.,
BJS in print) showed that laparoscopy and myopenia were
both independent predictors of survival in CRC patients
treated surgically when adjusted for confounding factors
such as BMI, age, UICC, and visceral adiposity. This
finding, combined with the results of this study, may be
extrapolated that increased adoption of laparoscopy for
CRC surgery may have a positive indirect impact upon
cancer survival.
GCM, the statistical methodology used, is an advanced
technique to determine individual growth profiles and to
address questions of stability over time, with a number of
advantages by comparison with other analytical methods.
First, it provides a more flexible way to analyse unbalanced
data with measurements that are inconsistent over time;
second, it allows investigators to analyse both intra- and
TABLE 4 Multivariate quadratic growth with random intercept and
random slope for patients LSMI
Skeletal muscle index Estimate (SE) p value
Fixed part
Gender
Female versus male -8.82 (0.88) \0.01
Age (years)
[65 versus\65 -3.52 (0.88) \0.01
NLR
HNLR versus LNLR -1.89 (0.85) 0.03
ASA
III ? IV versus I ? II -3.53 1.16 \0.01
Surgical approach
Laparoscopic versus Open -0.68 1.20 0.60
Tumor site
Rectum versus colon -0.91 0.89 0.31
UICC stage
III ? IV versus I ? II 0.27 0.86 0.75
Time*Laparoscopy 0.17 0.06 0.03
Time*Rectum -0.13 0.11 0.25
Time*Stage III ? IV -0.19 0.09 0.04
Time linear 0.75 0.30 0.01
Time quadratic -0.03 0.01 0.02
Random part
Bp 7.41 0.32
t
p
ij 0.29 0.11
nij constantð Þ 0.13 0.21
Residual 2.45 0.07
Log likelihood -3038.85
AIC 6111.71
BIC 6195.49
NLR neutrophil to lymphocyte ratio, ASA American Society of
Anesthesiologists, UICC Union for International Cancer Control,
HNLR high NLR, LNLR low NLR, SE standard error, AIC Akaike
Information Criterion, BIC Bayesian Information Criterion
Bolded p values indicate statistical significance at p\ 0.05
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FIG. 1 Mean trajectory and 95 % range of patient-specific trajecto-
ries of the LSMI for the different patient-level covariates from the
quadratic model. LMSI lumbar skeletal muscle index, ASA American
Society of Anesthesiologists, CT computed tomography, NLR
neutrophil to lymphocyte ratio, yo years old
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intersubject differences in the growth parameters (e.g.
slopes and intercepts); third, the effects of predictors at
higher levels and other predictors on individual growth can
flexibly be added in the GCM; and, finally, the GCM
approach is more powerful in examining the effects asso-
ciated with measures over time as it models the covariance
matrix (i.e. fitting the true covariance structure to the data),
rather than imposing a certain type of structure as is
commonly used in traditional univariate and multivariate
approaches.7
Limitations of this study include the fact that this was
an uncontrolled study despite comprising a relatively
large and homogenous data set. Electronic records of CT
scans were not available before 2007 as the PACS was
introduced in February that year and has contributed to
the exclusion from the study of a proportion of the St
Mark’s early cohort. BMI and other pathological markers,
such as grade of differentiation and lymphovascular
invasion, were not included in the analysis as previous
work from our group did not identify any significant
relationships between these parameters and the presence
of muscle depletion in CRC patients.23 Finally, the effect
of the postoperative outcomes on the LSMI trajectory,
and that of additional treatments such as adjuvant
chemotherapy, was not interrogated. To avoid confusion
with regard to the impact of the postoperative major
morbidity events, we analyzed CT scans requested only
for CRC follow-up purposes. The time point of the ini-
tiation and duration of the adjuvant chemotherapy
regimen made it extremely difficult to account for, in an
analysis that focused mainly on preoperative factors and
their impact on the muscle trajectory.
CONCLUSIONS
In patients undergoing CRC surgery, laparoscopy and
the absence of a significantly elevated SIR favors preser-
vation and restoration of muscle mass, postoperatively. The
emerging data from our study may permit the development
of new treatment protocols whereby monitoring and mod-
ifying body composition has therapeutic potential.
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